TNF and pulmonary fibrosis: As it was primarily considered a mitogen, anti-TNFα therapies have been evaluated in a variety of fibrotic disorders, but evidence suggests that these approaches may exacerbate disease severity, notably in pulmonary fibrosis (Thavarajah et al., 2009).